Pharmaceutical Protein Drug Development
Course, Master's level, 3FB031
Expand the information below to show details on how to apply and entry requirements.
Spring 2025
Spring 2025,
Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 20 January 2025–20 February 2025
- Language of instruction
- English
- Entry requirements
-
150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering, and Biological Drugs, 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 October 2024
- Application code
- UU-89219
Admitted or on the waiting list?
- Registration period
- 13 January 2025–19 January 2025
- Information on registration from the department
Expand the information below to show details on how to apply and entry requirements.
Spring 2026
Spring 2026,
Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 19 January 2026–19 February 2026
- Language of instruction
- English
- Entry requirements
-
150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering, and Biological Drugs, 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 October 2025
- Application code
- UU-89219
Admitted or on the waiting list?
About the course
Through the course, you will understand how to develop a protein-based biological drug further after the initial proposed design of the drug. You will work on designing experiments to analyse if the biological drug has the predicted effect and in-depth formulate which indication you should treat and which diagnostic tools can be used to find the right patient group. They will also develop a target products profile (TPP) for the drug candidate and based on this formulate a quality TPP. With this base, they will learn more about analytical tools that can be used during the process development of a drug and also gain an understanding of how the drug and/or its effects can be measured in biological samples by e.g. mass spectrometry.